Summary
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.
Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
New Strong Sell Stocks for May 15th
AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.
Avanos Medical Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 156 | $1,957.23 | $3,894.54 | $1,937.31 | 98.98% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 438 | $8,796.04 | $10,939.05 | $2,143.01 | 24.36% |
| BG Bart Gancher Intech Investment Management LLC | 123,154 | $1.73M | $3.08M | $1.34M | 77.59% |
 Anthony Scaramucci SkyBridge Capital II LLC | 2M | $25.13M | $49.95M | $24.82M | 98.77% |
| YA Yinka Akinsola Blue Trust Inc. | 51 | $609.44 | $1,273.72 | $664.28 | 109% |
Avanos Medical Inc. (AVNS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Avanos Medical Inc. ever had a stock split?
Avanos Medical Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | David C. Pacitti CEO | NYSE Exchange | 05350V106 CUSIP |
| US Country | 2,287 Employees | - Last Dividend | - Last Split | 21 Oct 2014 IPO Date |
Overview
Avanos Medical, Inc. is a pioneering medical technology company that plays a significant role in the global healthcare sector, providing advanced medical device solutions across North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Initially known as Halyard Health, Inc., the company underwent a rebranding to Avanos Medical, Inc. in June 2018, signifying its evolution and dedication to innovation in the medical field. Since its inception in 2014, and headquartered in Alpharetta, Georgia, Avanos is committed to improving patient outcomes by focusing on reducing reliance on opioids through its range of medical devices and solutions, catering to various aspects of patient care including chronic care, surgical pain relief, and interventional pain management. The company's strategic direct marketing approach, alongside partnerships with third-party distributors, enables it to effectively reach hospitals, healthcare providers, facilities, and end-users, ensuring broad access to its products and services around the globe.
Products and Services
Avanos Medical, Inc. offers an extensive portfolio of products and services designed to enhance patient care and recovery across several key areas:
- Chronic Care Products: Concentrated on improving digestive health, Avanos provides innovative solutions like the Mic-Key enteral feeding tubes designed for minimally invasive nutrition delivery, Corpak patient feeding solutions that ensure safe and effective nutritional support, and NeoMed neonatal and pediatric feeding solutions, which cater to the youngest patients requiring specialized feeding assistance.
- Non-Opioid Pain Solutions: With a focus on surgical pain and recovery, Avanos features products such as ON-Q and ambIT surgical pain pumps that deliver controlled pain relief, and the Game Ready system, which combines cold and compression therapy to accelerate recovery post-surgery. These solutions aim to reduce the need for opioid painkillers, offering safer alternatives for pain management.
- Interventional Pain Solutions: Avanos also specializes in minimally invasive therapies for chronic pain relief. This includes Coolief pain relief therapy, a sophisticated method for alleviating chronic pain, OrthogenRx's hyaluronic acid injection products for knee osteoarthritis, providing a non-surgical pain relief option, and Trident radiofrequency ablation products, which offer a targeted approach to treat chronic pain conditions effectively. These interventional solutions underscore the company's commitment to addressing pain management through innovative, less invasive methods.
